Wagner et al v. Eli Lilly and Company
Filing
32
PROTECTIVE ORDER, granting 31 Motion for Protective Order. Signed by Chief Judge Rosanna Malouf Peterson. (LR, Case Administrator)
1
2
3
4
5
UNITED STATES DISTRICT COURT
EASTERN DISTRICT OF WASHINGTON
6
7
KAREN WAGNER,
NO: 2:14-CV-270-RMP
Plaintiff,
8
v.
PROTECTIVE ORDER
9
10
11
ELI LILLY AND COMPANY, an
Indiana corporation,
Defendant.
12
13
WHEREAS, Plaintiff Karen Wagner and Defendant Eli Lilly and Company
14
(“Lilly”) jointly believe that entry of a protective order pursuant to Federal Rule of
15
Civil Procedure 26(c) should be applied to this matter;
16
WHEREAS, a protective order will expedite the flow of discovery material,
17
facilitate the prompt resolution of disputes over confidentiality, and adequately
18
protect confidential material;NOW, THEREFORE, having found good cause, it is
19
HEREBY ORDERED THAT the parties’ Stipulated Motion for Protective Order,
20
ECF No. 31, is GRANTED, and further:
21
PROTECTIVE ORDER ~ 1
1
2
3
4
5
1.
The following definitions shall apply to this Stipulation and Protective
Order of Confidentiality (“Order”):
a.
“Party” shall mean a party to this action, any employee of such party,
and any counsel for such party.
b.
“Documents”
shall
mean
all
“writings,”
“recordings,”
or
6
“photographic” materials as described and defined in Rule 1001 of the Federal Rules
7
of Evidence, including electronically stored information, whether produced or
8
created by a party or another person, and whether produced pursuant to Federal Rule
9
of Civil Procedure 34, pursuant to a subpoena, by agreement or otherwise. This shall
10
include, but not be restricted to, all interrogatory answers, responses to requests for
11
production or for admission(s), deposition testimony, and deposition exhibits.
12
c.
“Confidential Information” shall mean all documents or portions
13
thereof that the producing party reasonably and in good faith believes is subject to a
14
protective order under Federal Rule of Civil Procedure 26(c)(1).
15
16
17
18
19
d.
“Copies” shall mean any photocopies, reproductions, duplicates,
extracts, summaries, or descriptions of a document and/or Confidential Information.
e.
“Producing party” shall mean any party or its counsel or any other
person who produced the document(s) at issue.
f.
“Designating party” shall mean any party or its counsel or any
20
other person who has designated the document(s) at issue as confidential pursuant
21
to paragraph 3, below.
PROTECTIVE ORDER ~ 2
1
2
3
g.
“Receiving party” shall mean any party or its counsel or any other
person to whom Confidential Information is furnished.
h.
“Competitor of Lilly” means any current manufacturer, developer,
4
or seller of drugs other than Lilly or any person who, upon reasonable and good faith
5
inquiry, could be determined to be a current employee of any manufacturer or seller
6
of drugs other than Lilly.
7
i.
8
days following:
9
(1)
the Court’s entry of a stipulated dismissal, or
10
(2)
the Court’s entry of a voluntary dismissal, or
11
(3)
the entry of a final, non-appealable order disposing of the case.
12
2.
If Plaintiff receives Lilly documents that are not publicly available from
“Final conclusion of this litigation” shall mean the date fifteen (15)
13
any source other than Lilly that, upon reasonable and good faith inquiry, could be
14
determined to be documents authored or created by Lilly, Plaintiff will treat such
15
documents as confidential under the terms of this Protective Order. In the event
16
Plaintiff produces to Lilly pursuant to Rule 34 of the Federal Rules of Civil
17
Procedure any documents falling within this paragraph, Lilly shall have thirty (30)
18
days to designate said documents as confidential pursuant to paragraph 3. If Plaintiff
19
wishes to challenge the confidentiality of such a document, Plaintiff shall notify
20
Lilly in writing and append a copy of the document at issue. Lilly will have
21
thirty (30) days to provide a written response to Plaintiff’s challenge and, if the
PROTECTIVE ORDER ~ 3
1
parties reach an impasse following a good faith effort to resolve the dispute, Plaintiff
2
may bring a motion with the Court at any time thereafter.
3
3.
Any party shall have the right to designate any document the party
4
believes in good faith contains Confidential Information in that party’s custody or
5
control and that is not publicly available, or any portion of any document the party
6
believes in good faith contains Confidential Information, as “confidential” pursuant
7
to the following procedures:
8
9
10
a.
Subject to paragraph 3(c), below, designation of documents
as confidential shall be made:
(1)
in the case of documents in hardcopy form or in a modifiable electronic
11
format, by affixing the following legend to each page of the document, or
12
portion thereof, that is deemed by the producing party as confidential in such a way
13
so as not to obscure any part of the text or content:
14
CONFIDENTIAL — SUBJECT TO A PROTECTIVE ORDER
15
(2)
in the case of electronically stored documents (other than documents in
16
a modifiable electronic format), by noting in the metadata or on the image for each
17
document that the document is CONFIDENTIAL — SUBJECT TO A
18
PROTECTIVE ORDER. The following shall appear on any cover letter referring to
19
electronically stored documents and, to the extent possible, to the device (i.e. disc,
20
hard drive, etc.) on which the documents are electronically stored:
21
CONFIDENTIAL — SUBJECT TO A PROTECTIVE ORDER
PROTECTIVE ORDER ~ 4
1
KAREN WAGNER v. ELI LILLY AND COMPANY
2
USDC Eastern District of Washington
3
In the event electronically stored documents designated as confidential are
4
produced in a native format, whenever the party to whom such documents are
5
produced reduces such material to hardcopy form, that party shall designate the
6
hardcopy documents with the legend as provided in paragraph 3(a)(1), above.
7
8
9
b.
Subject to paragraph 3(d), below, designation of documents
as confidential will be made before or at the time of production or disclosure.
c.
To the extent that any party has heretofore designated certain
10
documents as confidential, it will not be required to re-designate the same with the
11
full legend set out in paragraph 3(a), above.
12
d.
The inadvertent failure to designate a document or any portion thereof
13
as confidential does not alter or waive the protected and confidential nature of the
14
document or portion thereof and does not remove it from the scope of this Order.
15
The party discovering such inadvertent failure to designate a document or portion
16
thereof as confidential shall, within fifteen (15) days of such discovery, notify
17
counsel for the receiving party in writing that the document or a specified portion
18
thereof is to be designated as confidential under the terms of this Order.
19
e.
Interrogatory answers; responses to requests for admission; responses
20
to requests for production; deposition transcripts and exhibits; and pleadings,
21
motions, affidavits, briefs, or other papers filed with the Court that include quotes
PROTECTIVE ORDER ~ 5
1
of, summaries of, or copies of documents entitled to protection may be accorded
2
status as Confidential Information but, to the extent feasible, shall be prepared in
3
such a manner that the Confidential Information is bound separately from the
4
portions of the document not entitled to protection.
5
4.
The party designating information, documents, materials, or items
6
as Confidential Information bears the burden of establishing confidentiality. If a
7
party in good faith disagrees with a confidential designation:
8
9
10
a.
The party seeking to challenge any confidential designation will
inform counsel for the designating party in writing of said disagreement.
b.
Upon the designating party’s receipt of written notification that there is
11
a disagreement on a confidentiality designation, the producing party will have thirty
12
(30) days to provide a written response. The parties will confer in an effort to resolve
13
the dispute without Court intervention.
14
c.
If, after conferring, the parties cannot resolve the dispute despite
15
good-faith efforts to do so, any party may move for a determination by the Court as
16
to the appropriateness of the confidential designation. In accordance with LR
17
37.1(b), “[a]t least 14 days before the date of the hearing, the parties shall file a
18
statement setting forth the matters on which they have been unable to agree.” The
19
proponent of confidentiality must show by a preponderance of the evidence that
20
there is good cause for the document or portion thereof to have such protection.
21
PROTECTIVE ORDER ~ 6
1
d.
Each document or portion thereof designated as confidential shall
2
retain that designation and shall remain subject to the terms of this Order until such
3
time, if ever, that the Court renders a decision that a particular document or portion
4
thereof is not subject to this Order and any and all proceedings or interlocutory
5
appeals challenging such decision have been concluded.
6
5.
The producing party may redact the following information:
7
a.
names, addresses, Social Security numbers, tax identification
8
numbers, email addresses, telephone numbers, and any other information that would
9
identify patients (other than Plaintiff);
10
b.
names, addresses, Social Security numbers, tax identification
11
numbers, email addresses, telephone numbers and any other personal identifying
12
information of health care providers, including, but not limited to, individuals,
13
organizations, or facilities that furnish, bill, or are paid for healthcare services or
14
supplies;
15
c.
names, addresses, Social Security numbers, tax identification
16
numbers, email addresses, telephone numbers, and any other personal identifying
17
information (not to include race, age, or gender) of individuals enrolled as subjects
18
in clinical studies or identified in adverse event reports;
19
d.
street addresses, Social Security numbers, tax identification
20
numbers, dates of birth, home telephone numbers, and cellular telephone numbers
21
of employees;
PROTECTIVE ORDER ~ 7
1
e.
names, addresses, Social Security numbers, tax identification
2
numbers, email addresses, telephone numbers, and other personal identifying
3
information of any clinical investigator involved in the reporting of an adverse event;
4
f.
personal information not the specific focus of the request;
5
g.
information necessary to comply with privacy rights that are
6
guaranteed by the Washington Constitution, the United States Constitution, the Code
7
of Federal Regulations, the Health Insurance Portability and Accountability Act of
8
1996, and other applicable laws and regulations. See, e.g., 21 C.F.R. §§ 20.111,
9
20.63, and 314.80; 45 C.F.R. §§ 160 and 164; and
10
h.
materials that contain information protected from disclosure by
11
the attorney-client privilege or the work product doctrine, which shall be identified
12
in a privilege log that shall be provided to the receiving party within ninety (90) days
13
of production.
14
6.
15
16
Redaction of material pursuant to paragraph 5 is subject to the
following:
a.
The redacting party shall, upon written or oral request, identify the
17
nature of the information redacted in a specific document with sufficient detail to
18
allow the requesting party to determine whether a challenge to the redacted
19
information may be appropriate.
20
21
PROTECTIVE ORDER ~ 8
1
b.
If the requesting party has a good-faith basis for challenging
2
the redaction, that party shall promptly inform counsel for the redacting party in
3
writing of said challenge.
4
c.
If, after conferring, the parties cannot resolve the dispute despite
5
good-faith efforts to do so, the party challenging the redaction may move the Court
6
for a ruling on the issue of whether certain information is entitled to redaction. The
7
party that has redacted the information must show by a preponderance of the
8
evidence that the redacted document or portion thereof is redacted pursuant to the
9
relevant terms of paragraph 5, above, or is otherwise valid under applicable law. If
10
the Court finds that said information should remain redacted, said information shall
11
remain redacted and may not be used as evidence by either party at trial or at a
12
hearing or be relied upon by either party’s experts.
13
said information should not remain redacted, the redacting party shall provide an
14
unredacted version of the document within fifteen (15) days of the Court’s decision
15
or, if the redacting party challenges such a decision, within fifteen (15) days of the
16
conclusion of any and all proceedings or interlocutory appeals challenging the
17
decision.
18
7.
If the Court finds that
Counsel of record for the party receiving Confidential Information shall
19
use reasonable efforts to limit the disclosure of Confidential Information, including
20
any copies thereof, to the minimum number of persons necessary to conduct this
21
litigation. All copies of Confidential Information shall immediately be affixed with
PROTECTIVE ORDER ~ 9
1
the confidentiality legend pursuant to the provisions of paragraph 3(a), above, if the
2
legend does not already appear on the copy. All such copies shall be afforded the
3
full protection of this Order.
4
8.
Except as otherwise provided herein, or with the prior written consent
5
of the party or other person originally designating a document as confidential,
6
Confidential Information may be disclosed to the following persons:
7
a.
the Court, the Court’s clerk(s), staff, employees, any Court-
8
appointed Special or Discovery Master, any Court-appointed mediator, any mediator
9
agreed to by the parties, and any court reporter or videographer transcribing or
10
recording testimony, whether at a deposition, hearing, or trial;
11
b.
any named party;
12
c.
any attorney appearing as of record and any employee, agent,
13
14
15
16
or representative of said attorney;
d.
any person designated by the Court, in the interest of justice, upon
such terms as the Court may deem proper;
e.
any
physician,
nurse
practitioner,
medical
professional,
or
17
other healthcare provider, and any employee or agent thereof, who prescribed
18
Cymbalta for Plaintiff Karen Wagner or who provided care or treatment to Karen
19
Wagner during or following her cessation of Cymbalta. For the sake of clarity, the
20
procedures set forth in Paragraph 9, below, which govern disclosure of Confidential
21
PROTECTIVE ORDER ~ 10
1
Information to parties listed in Paragraph 8(f), shall not apply to the healthcare
2
providers identified in this paragraph;
3
f.
Subject to the provisions of Paragraph 9, below, any of the following:
4
(1)
any non-party witness appearing to testify at a deposition;
5
(2)
any person with prior knowledge of the Confidential Information;
6
(3)
any consultant or expert retained for the purpose of assisting counsel in
7
8
the lawsuit;
(4)
any employee or third-party contractor of counsel involved
9
in organizing, filing, coding, converting, storing, or retrieving data or in designing
10
programs for handling documents or data connected with these actions, including
11
the performance of such duties in relation to a computerized litigation support
12
system; and
13
(5)
14
trial preparation.
15
16
17
9.
any employee or third-party contractor of counsel involved in
Before disclosing Confidential Information to any person listed in
paragraph 8(f), above, the receiving party shall:
a.
ensure that the individual to whom disclosure is to be made has
18
been provided a copy of this Order and executed the Confidentiality Agreement
19
attached hereto as Exhibit A, thereby agreeing to be bound by the terms of this Order
20
concerning receipt and disclosure of Confidential Information; and
21
PROTECTIVE ORDER ~ 11
1
b.
prepare a log providing the name, address, place of employment,
2
and employment capacity of each such person to whom disclosure of Confidential
3
Information is made, together with a copy of the Confidentiality Agreement
4
executed by that person. The receiving party shall maintain said log and the signed
5
copies of the Confidential Agreement for five (5) years following the final
6
conclusion of this litigation. The contents of said log shall be privileged and shall
7
not be subject to disclosure absent an order by the Court.
8
10.
Subject to the provisions of paragraphs 8 and 9, above, no disclosure
9
of Confidential Information shall be made to any Competitor of Lilly. In the event
10
any disclosure of Confidential Information to a Competitor of Lilly is anticipated,
11
the disclosing party shall provide written notice no fewer than fifteen (15) days prior
12
to any disclosure identifying the Competitor of Lilly to whom Confidential
13
Information will be disclosed and specifying the Bates number of the Confidential
14
Information to be disclosed. Lilly shall have fifteen (15) days within which to object
15
in writing to any proposed disclosure pursuant to this Paragraph.
16
11.
Persons obtaining access to Confidential Information under this Order
17
shall use the information for preparation and trial (including appeals and retrials)
18
related to Cymbalta discontinuation litigation, and, to the extent it is used in related
19
actions, subject to the protective orders in those related actions. Persons obtaining
20
access to Confidential Information shall not use such information for any other
21
PROTECTIVE ORDER ~ 12
1
purpose, including, but not limited to, business, governmental, commercial, or
2
administrative or unrelated judicial proceedings.
3
12.
Any party or person to whom Confidential Information has been
4
furnished who receives from any non-party (including natural persons, corporations,
5
partnerships, firms, governmental agencies, departments or bodies, boards, or
6
associations) a subpoena or other process that seeks production or disclosure of such
7
Confidential Information shall promptly, and in any case by the close of the next
8
business day, give telephonic notice or written notice by overnight delivery, email,
9
or facsimile to counsel for the designating party. Both the telephonic notice and/or
10
the written notice shall identify the documents sought and the return date of the
11
subpoena or other process, and the written notice shall also include a copy of
12
the subpoena or other process. The party or person receiving the subpoena shall also
13
inform the person seeking the Confidential Information that such information is
14
subject to this Order. No production or other disclosure of such information pursuant
15
to the subpoena or other process shall occur before ten (10) days following the date
16
on which notice is given, or the return date of the subpoena, whichever is earlier.
17
13.
The parties shall maintain privilege logs pursuant to Federal Rule of
18
Civil Procedure 26(b)(5). A privilege log shall be provided within ninety (90) days
19
after each production of documents by a party except that a receiving party shall be
20
permitted to request from the producing party that a privilege log for a particular
21
PROTECTIVE ORDER ~ 13
1
production be provided within a shorter time period if the receiving party has a good
2
faith basis for such a request in connection with a scheduled deposition.
3
a.
No
party
is
required
to
list
on
a
privilege
log
any
4
communications regarding the claims and defenses in these proceedings exclusively
5
between a party and its in-house counsel, outside counsel, an agent of outside
6
counsel other than the party, any non-testifying experts, and, with respect to
7
information protected by Fed. R. Civ. P. 26(b)(4), testifying experts.
8
b.
No party is required to list on a privilege log any privileged materials
9
or work product created after November 1, 2012, by its in-house counsel, outside
10
counsel, an agent of outside counsel other than the party, any non-testifying experts,
11
and, with respect to information protected by Fed. R. Civ. P. 26(b)(4), testifying
12
experts.
13
c.
If a producing party identifies portions of discoverable information
14
that are privileged and redacts such portions of the discoverable information on that
15
basis, the producing party does not need to log the fact of redaction so long as, for
16
e-mails, the bibliographic information (i.e., to, from, cc, bcc, date/time) is not
17
redacted; and, for non-email documents, the redaction is noted on the face of the
18
document.
19
redactions: Confidential Employee Information (“CEI”), Confidential Investigator
20
Personal Information (“CII”), Confidential Patient Information (“CPI”), AC
21
Privilege, WP Privilege, and AC/WP Privilege.
The following terms will be used to signify the reasons for any
PROTECTIVE ORDER ~ 14
1
d.
A party’s privilege log only needs to provide objective metadata (to
2
the extent it is reasonably available and does not reflect privileged or protected
3
information) and an indication of the privilege or protection being asserted.
4
e.
If a party receiving a privilege log has a good-faith basis for
5
challenging a producing party’s privilege determination, the receiving party shall
6
inform counsel for the producing party in writing. The producing party will have
7
thirty (30) days to provide a written response.
8
f.
If, after conferring, the parties cannot resolve the dispute despite
9
good-faith efforts to do so, the party challenging a privilege determination may move
10
the Court for a ruling on the issue of privilege. In accordance with LR 37.1(b), “[a]t
11
least 14 days before the date of the hearing, the parties shall file a statement setting
12
forth the matters on which they have been unable to agree.” The producing party
13
must show by a preponderance of the evidence that the withheld document or portion
14
thereof is privileged, as set forth in paragraph 6.c.
15
14.
Inadvertent production of documents subject to work-product
16
immunity, the attorney-client privilege, or other legal privilege protecting
17
information from discovery shall not constitute a waiver of the immunity or
18
privilege. With respect to such inadvertently produced documents, the following
19
procedures shall apply, and the parties agree that such procedures constitute
20
reasonable and prompt steps to prevent disclosure and to rectify the error of
21
disclosure, pursuant to the Federal Rules of Civil Procedure:
PROTECTIVE ORDER ~ 15
1
2
3
a.
The party discovering the inadvertent production will contact
the opposing party to apprise that party of such production promptly.
b.
If
no
dispute
exists
as
to
the
protected
nature
of
the
4
inadvertently produced documents, any party in possession of inadvertently
5
produced documents (“party in possession”) shall, within fifteen (15) days of
6
receiving the notice of inadvertent production, destroy the inadvertently produced
7
documents along with any copies and notes or other work product reflecting the
8
contents of such documents, including the deletion of all inadvertently produced
9
documents from any litigation-support or other database. The party in possession
10
of the inadvertently produced documents shall certify the destruction and deliver the
11
certification to the producing party within the fifteen (15)-day period. In the event
12
that only portions of the inadvertently produced documents contain privileged
13
subject matter, the producing party shall substitute redacted versions of the
14
documents within ten (10) days of the certification of destruction of the inadvertently
15
produced documents.
16
c.
If the party in possession believes that the documents are not subject
17
to the protections of work-product immunity, attorney-client privilege, or other legal
18
privilege protecting information from discovery, the party in possession shall, within
19
fifteen (15) days of sending or receiving the notice of inadvertent production, object
20
to the producing party’s claim of protection by notifying the producing party of the
21
objection in writing and specifically identifying the produced documents to which
PROTECTIVE ORDER ~ 16
1
the objection applies. Upon the producing party’s receipt of written notification, the
2
parties will confer in an effort to resolve the dispute without Court intervention. If
3
the parties cannot resolve the dispute, any party can, within fifteen (15) days of
4
reaching an impasse, contact the Court to seek an in camera review of the documents
5
in question. The proponent of the privilege and/or immunity has the burden of
6
proving by a preponderance of the evidence that the inadvertently produced
7
documents are entitled to protection. If the Court determines that the inadvertently
8
produced documents are entitled to work-product immunity, attorney-client
9
privilege, or other legal privilege protecting information from discovery, the party
10
in possession shall, within fifteen (15) days of the Court’s decision, comply with the
11
provisions of paragraph 14(b), above.
12
d.
Upon receipt of notice of inadvertent production pursuant to
13
paragraph 14(a), above, and until the parties have resolved the issue pursuant to
14
paragraph 14(b) or (c), no use shall be made of inadvertently produced documents
15
during depositions or at trial, nor shall they be disclosed to anyone who did not
16
previously have access to them.
17
e.
The Parties agree that employing electronic keyword searching
18
to identify and prevent disclosure of privileged material constitutes “reasonable steps
19
to prevent disclosure” under Federal Rule of Evidence 502(b)(2). Pursuant to
20
Federal Rule of Evidence 502(d) and (e), the production of any discovery material
21
by any party, whether inadvertent or not, shall be without prejudice to any
PROTECTIVE ORDER ~ 17
1
subsequent claim by the producing party that such discovery material is privileged
2
or attorney-work product, and shall not be deemed a waiver of any such privilege or
3
protection in either the litigation pending before the court, or any other federal or
4
state proceeding.
5
15.
Failure to assert work-product immunity, the attorney-client privilege,
6
and/or other legal privilege protecting information from discovery in this lawsuit as
7
to one document shall not be deemed to constitute a waiver, in whole or in part, of
8
any work product immunity and/or privilege protection as to any other document,
9
even if the documents involve the same or similar subject matter.
10
16.
A deponent may be shown and examined about Confidential
11
Information during a deposition subject to the terms of paragraphs 8 and 9, above.
12
Deponents shall not retain or copy portions of the transcript of their depositions that
13
contain Confidential Information not provided by them or their counsel. While a
14
deponent is being examined about any Confidential Information, persons to whom
15
disclosure is not authorized under this Order shall not be present.
16
17.
Parties and deponents may, within thirty (30) days after receiving a
17
deposition transcript, designate pages of the transcript and/or deposition exhibits as
18
confidential. Confidential Information within the deposition transcript may be
19
designated by underlining the portions of the pages that are confidential and marking
20
such pages with the confidentiality legend pursuant to the provisions of paragraph
21
3(a), above. Until expiration of the thirty (30)-day period, the entire deposition will
PROTECTIVE ORDER ~ 18
1
be treated as subject to protection against disclosure under this Order. If no party or
2
deponent timely designates Confidential Information in a deposition, none of the
3
transcript or its exhibits will be treated as confidential. If a timely designation is
4
made, the confidential portions and exhibits shall be filed under seal, separate from
5
the portions and exhibits not so designated and all copies of the confidential portions
6
and exhibits shall be treated as Confidential Information pursuant to the terms of this
7
Order. If any party in good faith disagrees with a confidential designation of any
8
portion of a deposition transcript or of any deposition exhibit, the procedures of
9
paragraph 4, above, will govern.
10
18.
Subject to the Federal Rules of Civil Procedure, the Federal Rules of
11
Evidence, and Local Rules of this Court, Confidential Information may be offered
12
into evidence at trial or any court proceeding.
13
a.
If a party wishes to use Confidential Information during a
14
Court proceeding or hearing other than trial, the proponent of the evidence must give
15
two (2) days’ advance notice in writing to the designating party prior to offering the
16
evidence. This provision does not apply to depositions.
17
b.
If the proponent of the evidence wishes to use Confidential
18
Information at trial, the proponent of the evidence must give timely written notice to
19
the designating party prior to offering the evidence (e.g., provision of an exhibit list
20
identifying the Confidential Information). Any party may move the Court for an
21
order that the evidence be received in camera or under other conditions to prevent
PROTECTIVE ORDER ~ 19
1
unnecessary disclosure. In such case, the Court will determine whether the proffered
2
evidence should continue to be treated as Confidential Information and, if so, what
3
protection, if any, may be afforded to such information.
4
19.
Use of Confidential Information in Court. Absent a written agreement
5
to the contrary by the designating party, any Confidential Information of any type
6
filed in support of a motion or other matter pending before the Court shall be filed
7
under seal in accord with the Local Rules.
8
9
10
11
20.
Nothing in this Order shall preclude a party from introducing into
evidence at trial or hearing any Confidential Information that is admissible under the
Federal Rules of Evidence.
21.
Nothing in this Order shall prevent or otherwise restrict counsel from
12
rendering advice to their clients in this lawsuit and, in the course thereof, relying
13
generally on examination of Confidential Information, provided that, in rendering
14
such advice and otherwise communicating with a client, counsel shall not make
15
specific disclosure of any Confidential Information except pursuant to the provisions
16
of this Order. Counsel shall at all times keep secure all notes, abstractions, or other
17
work product derived from or containing Confidential Information and shall be
18
obligated to maintain the confidentiality of such work product, even after the
19
documents designated as confidential have been returned or destroyed pursuant
20
to paragraph 23, below.
21
PROTECTIVE ORDER ~ 20
1
22.
The provisions of this Order shall not terminate at the final conclusion
2
of this litigation. This Order shall remain in full force and effect in perpetuity unless
3
modified, superseded, or terminated by written consent of the parties or by order of
4
the Court. Each person subject to this Order shall continue to be subject to the
5
jurisdiction of the United States District Court for the Eastern District of Washington
6
for the purpose of enforcement of the terms of this Order for as long as the Order
7
remains in effect. The Court shall not be divested of the power to enforce the terms
8
of this Order as to any persons subject to the Order by the final conclusion of this
9
litigation or by the filing of a notice of appeal or other pleading that arguably has the
10
11
effect of divesting this Court of jurisdiction of this matter generally.
23.
Within sixty (60) days after the final conclusion of this litigation
12
(including without limitation any appeals and after the time for filing all appellate
13
proceedings has passed):
14
15
a.
Confidential Information and, subject to paragraph 23(b) and (c),
below, all copies of same (other than exhibits of record) shall either:
16
(1)
be returned to the producing party, or
17
(2)
at the option of the producing party (if it retains at least one copy of the
18
designated document), be destroyed.
19
All parties shall make certification of compliance with this paragraph and
20
shall deliver the same to the producing party not more than sixty (60) days after the
21
final conclusion of this litigation.
PROTECTIVE ORDER ~ 21
1
b.
Unless otherwise ordered by the Court, counsel may retain: (1) copies
2
of pleadings or other papers that have been filed with the Court that contain
3
Confidential Information, including exhibits thereto; (2) work product containing
4
Confidential Information; and (3) official transcripts and exhibits thereto. Any
5
documents retained following the final conclusion of the litigation will be
6
maintained as confidential and subject to the contents of this protective order.
7
c.
The receiving party shall make a reasonable effort to retrieve
8
any Confidential Information from any non-party to whom such information has
9
been given, and shall notify the producing party in writing of the failure to retrieve
10
any such documents. This notice shall (1) specifically identify the Confidential
11
Information not returned, (2) identify the person from whom the Confidential
12
Information could not be retrieved, and (3) state the efforts made to retrieve such
13
Confidential Information and the reasons these efforts were unsuccessful.
14
24.
Nothing in this Order shall prevent any party or other person from
15
seeking modification of this Order or from objecting to discovery that it believes to
16
be otherwise improper. The parties shall be given notice and an opportunity to be
17
heard before the Court on any matter that in any way modifies this Order or may
18
result in a decision affecting the substance or effect of this Order.
19
20
25.
Nothing herein shall prevent any party from disclosing any document
that it has produced to any other person or shall otherwise restrict the use of such
21
PROTECTIVE ORDER ~ 22
1
documents by the producing party. Such use and/or disclosure shall not be deemed
2
to waive or otherwise modify the protection or confidentiality provided in this Order.
3
26.
Any party may expressly waive in writing the applicability of any
4
provision of this Order to any document or portion thereof that the party produces.
5
Such waiver shall apply only to the document or portion thereof to which the
6
applicability of the specified provision of this Order is expressly waived.
7
27.
Any material violation of this Order by any party or person to
8
whom Confidential Information is disclosed pursuant to the terms of the Order shall
9
constitute a violation of a court order and be punishable as such.
10
28.
GOOD CAUSE: Good cause exists to issue a protective order in this
11
case because disclosure and discovery activity in this action are likely to involve
12
production of confidential, proprietary, or private information that qualify for
13
protection under Federal Rule of Civil Procedure 26(c). Defendant’s Confidential
14
Information includes, but is not limited to: information on corporate organization;
15
IND/NDA submissions and information relating to product development;
16
communications with FDA and state regulatory agencies; marketing research, plans
17
and summaries; sales representative information, records and communications; sales
18
representative training materials; financial and business information and records;
19
external consultant work product and communications; Standard Operating
20
Procedures and manuals; and product safety information. Plaintiff’s Confidential
21
PROTECTIVE ORDER ~ 23
1
Information includes, but is not limited to, Plaintiff Karen Wagner’s medical,
2
financial, and/or employment records.
3
IT IS SO ORDERED.
4
The District Court Clerk is directed to enter this Order and provide copies to
5
6
counsel.
DATED this 21st day of September 2015.
7
8
s/ Rosanna Malouf Peterson
ROSANNA MALOUF PETERSON
Chief United States District Court Judge
9
10
11
12
13
14
15
16
17
18
19
20
21
PROTECTIVE ORDER ~ 24
Disclaimer: Justia Dockets & Filings provides public litigation records from the federal appellate and district courts. These filings and docket sheets should not be considered findings of fact or liability, nor do they necessarily reflect the view of Justia.
Why Is My Information Online?